Rossari Biotech Ltd · NSE:ROSSARI
Rossari Biotech — Q1 FY27 Earnings Presentation
30 slides from Rossari Biotech's earnings presentation, Jul 19, 2026
Slide 1: Exchange filing cover letter for Q1 FY27 earnings presentation
July 19, 2026 DCS-CRD Listing Compliance BSE Limited National Stock Exchange of India Limited First Floor, New Trade Wing Exchange Plaza, 5th Floor Rotunda Building, Phiroze Jeejeebhoy Towers Plot No. C/1, ‘G’ Block, Bandra- Kurla Complex Dalal Street, Fort Mumbai 400001 Bandra East Mumbai 400051 Fa
Slide 2: Q1 FY27 Results Presentation
ROSSARI BIOTECH LIMITED Q1 FY27 RESULTS PRESENTATION July 18, 2026
Slide 3: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”) reflect various assumptions concerning the strategies, objectives and anticipated results which may or may not prove to be
Slide 4: Q1 FY27 Results Overview, Company Overview, Annexure
1 Q1 FY27 Results Overview 2 Company Overview 3 Annexure 3
Slide 5: Q1 FY27 – Key Financial Highlights
Q1 FY27 – Key Financial Highlights Record Quarterly Revenue and EBITDA Revenue from Operations (Rs. cr) EBITDA(Rs. cr) PAT(Rs. cr) 697.2 684.9 46.0 80.6 77.3 543.7 67.9 35.1 33.6 Q1 FY27 Q4 FY26 Q1 FY26 Q1 FY27 Q4 FY26 Q1 FY26 Q1 FY27 Q4 FY26 Q1 FY26 Shift % (Y-o-Y) 28.2% 18.7% 4.5% Shift % (Q-o-Q)
Slide 6: Institutional and B2C Performance – Incubating Future Growth Verticals in Health & Hygiene
Institutional and B2C Performance – Incubating Future Growth Verticals in Health & Hygiene Revenue (Rs. cr) EBITDA (Rs. cr) Q1 FY27 Q4 FY26 Q1 FY26 71 70 70 (2) (4) (7) Q1 FY27 Q4 FY26 Q1 FY26 Shift % (Y-o-Y) 1% 43% Shift % (Q-o-Q) 1% -100% Margins (%) -6% -3% -10% • Performance in the Institutional
Slide 7: Consolidated Performance excluding Institutional and B2C Businesses
Consolidated Performance excluding Institutional and B2C Businesses Revenue (Rs. cr) EBITDA (Rs. cr) 85 626 79 75 615 474 Q1 FY27 Q4 FY26 Q1 FY26 Q1 FY27 Q4 FY26 Q1 FY26 Shift % (Y-o-Y) 32% 13% Shift % (Q-o-Q) 2% 8% Margins (%) 14% 13% 16% • Core segments delivered strong growth, supported by a dive
Slide 8: Past Financial Performance Snapshot
Past Financial Performance Snapshot Revenue (Rs. cr) EBITDA (Rs. cr) PAT (Rs. cr) CAGR – 13% CAGR – 9% CAGR – 12% 149 286 131 136 2,396 250 265 2,080 223 107 1,656 1,831 FY23 FY24 FY25 FY26 FY23 FY24 FY25 FY26 FY23 FY24 FY25 FY26 Exports (Rs. cr) ROE (%) ROCE (%) Net Debt to Equity (x) CAGR – 19% 21
Slide 9: Management Message
Management Message Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We commenced FY27 on a strong note, delivering robust consolidated revenue growth of 28% YoY. The performance was driven
Slide 10: Key Developments
Key Developments • Strengthened Southeast Asia Presence through Thailand Facility o Established a greenfield blending facility in Thailand through the Company’s subsidiary, Unistar Thai o Installed capacity of 5,000 MTPA, with capabilities across powders, granules and liquids o Designed to offer cus
Slide 11: Abridged P&L Statement - Consolidated
Abridged P&L Statement - Consolidated Particulars (Rs. cr) Q1 FY27 Q1 FY26 Y-o-Y FY26 FY25 Y-o-Y Revenues from Operations 697.2 543.7 28.2% 2,396.4 2,080.3 15.2% Total Expenditure COGS 490.8 371.3 32.2% 1,668.7 1,433.3 16.4% Employee benefits expense 44.1 37.5 17.6% 154.7 132.3 16.9% Other expenses
Slide 12: Segment-wise Operating Performance
Segment-wise Operating Performance Quarterly Revenue Break-up (Rs. cr) Q1 FY27 Q4 FY26 Q1 FY26 697 685 553 530 544 431 106 113 83 38 42 30 HPPC TSC AHN TOTAL Shift (Y-o-Y) % 28% 28% 27% 28% Shift (Q-o-Q) % 4% -6% -10% 2% Note: 1) All figures, unless mentioned otherwise, are on a consolidated basis 2
Slide 13: Q4 FY26 Results Overview, Company Overview, Annexure
1 Q4 FY26 Results Overview 2 Company Overview 3 Annexure 12
Slide 14: Rossari – At a Glance
Rossari – At a Glance Technocrat promoters with 25% 75+ Revenue CAGR % (FY19-26) cumulative years of experience in the specialty chemicals industry 8* 4* 13% Manufacturing R&D Contribution of Top 10 customers facilities Facilities in FY26 387,100* MTPA 18% Capacity Installed PAT CAGR % (FY19-26) Est
Slide 15: A 25-Year Journey of Transformation
A 25-Year Journey of Transformation Delivering Value and Maintaining Synergy Along the Way Looking back in time Our Company was initially incorporated as ‘Rossari Labtech’ in March, 2003, as a partnership firm. In the same year, in December, the name of the partnership firm was changed to ‘Rossari B
Slide 16: HPPC | Home, Personal Care and Performance Chemicals
Business Overview HPPC | Home, Personal Care and Performance Chemicals One of the Fastest-growing Specialty Chemicals Manufacturers in the HPPC Sector in India Key Metrics as of FY26 77% FY26 Rev. 80 1,750+ 1,050+ 100+ Geographies Customers Products New Products (L3Y) KEY GROWTH DRIVERS Rising Deman
Slide 17: TSC | Textile Specialty Chemicals
Business Overview TSC | Textile Specialty Chemicals One of the Largest Textile Specialty Chemical Manufacturers in India Serving the Full Textile Value Chain From Fibre to Finished Fabric Key Metrics as of FY26 17% FY26 Rev. 29 1,000+ 2,000+ 21+ Geographies Customers Products New Products (L3Y) KEY
Slide 18: AHN | Animal Health Nutrition
Business Overview AHN | Animal Health Nutrition Manufactures a Range of Bio-Based Feed Supplements and Additives, Pet Grooming and Pet Treats by Leveraging Expertise in Life Sciences Key Metrics as of FY26 6% FY26 Rev. 18 125+ 90+ 30+ Geographies Customers Products New Products (L3Y) KEY GROWTH DRIV
Slide 19: Strong Competitive Edge
Strong Competitive Edge Deep relationships with marquee customers and Innovation-driven a growing global differentiation footprint Manufacturing Proven M&A and excellence supported by partnership record with strategic capacity effective integration augmentation Comprehensive product Sustainable valu
Slide 20: Robust Manufacturing Capabilities
Robust Manufacturing Capabilities Unitop Dahej Plant Manufacturing Facility at Dahej 90,000 MTPA • Enjoys proximity to multi-cargo port of Dahej – providing cost & logistical Tristar Sarigam Plant advantage • State-of-the-art facility, well-equipped with advanced technologies 15,000 MTPA • Designed
Slide 21: Growing Global Reach
Growing Global Reach Market Presence RoW India 26% 74% EXPORT OPERATIONS IN 80+ COUNTRIES As of FY26
Slide 22: Key Strategic Levers for Growth
Key Strategic Levers for Growth Accelerating growth in core Strengthening 01 business lines 04 international presence • Deepen customer engagement through cross- • Expand international distribution across key sell and solution-led offerings markets • Increase wallet share across domestic and • Broad
Slide 23: Update on Key Subsidiaries
Update on Key Subsidiaries Executed synergistic acquisitions in the past complementing the ethos of Rossari’s business model Description Rationale Revenue (Rs. crore) • Unitop solutions sold across 25+ countries CAGR – 19% • Presence in high-potential Specialty • Expand into surfactants and 922 chem
Slide 24: Key Synergies from Acquisitions
Key Synergies from Acquisitions Strategic & value-accretive acquisitions accelerate growth and drive economies of scale Synergies Realised Value Creation Augmented presence in Specialty • Integrated Chemical, Personal Care and manufacturing led to Agrochemical segments cost saving • Strengthened pre
Slide 25: Focus on Green & Sustainable Chemical Solutions since Inception
Focus on Green & Sustainable Chemical Solutions since Inception Aggressively embracing sustainability in business operations to accelerate growth Operates three Zero Liquid Discharge Specialists in eco-friendly substitutes (ZLD) sites with rainwater harvesting, replacing harmful legacy products, wit
Slide 26: Corporate Social Responsibility
Corporate Social Responsibility We at Rossari, recognize our role and responsibility to deliver sustainable value to communities. Our initiatives are aimed towards upliftment of areas of rural development, women empowerment and livelihood opportunities, research and development for upliftment of soc
Slide 27: Experienced Promoters and Board of Directors
Experienced Promoters and Board of Directors Founders & Promoters Independent Directors • Over 25 years of experience in the banking industry. He holds a bachelor’s degree in • B. Sc. (chemistry major) from K. J. Somaiya College of commerce from H. L. Commerce College, Gujarat University. He is an a
Slide 28: Conference Call Details
CONFERENCE CALL DETAILS Q1 FY-2027 Earnings Conference Call Time 5:00 PM IST on Monday, July 20, 2026 Pre-registration To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Diamond Pass Registration (choruscall.i
Slide 29: About Us
About Us Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Specialty-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, India, the Company operates strategically located manufacturing facilities at Silvas
Slide 30: Thank you
Thank y#u ‘making you more compete 29